IRadimed Corporation
IRMD
$94.94
-$2.26-2.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.44% | 17.81% | 13.32% | 13.37% | -0.35% |
| Total Depreciation and Amortization | 94.18% | 4.22% | -14.15% | -5.11% | 4.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.02% | 134.36% | -3.92% | -15.84% | 41.96% |
| Change in Net Operating Assets | -92.87% | -40.29% | -2.44% | 115.74% | 171.23% |
| Cash from Operations | -23.36% | 16.69% | 10.53% | 53.02% | 554.53% |
| Capital Expenditure | 70.14% | -132.36% | -1,266.41% | -424.57% | -1,136.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.52% | -38.75% | -5.57% | -164.22% | -53.93% |
| Cash from Investing | 68.50% | -122.37% | -718.15% | -383.04% | -813.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -84.47% | -- |
| Repurchase of Common Stock | -66.29% | -50.23% | -82.00% | -25.58% | 43.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.79% | -13.79% | 72.90% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.28% | -15.17% | 71.67% | -820.60% | -6,009.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.81% | -21.82% | 58.95% | -83.00% | 245.43% |